UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000052486 |
|---|---|
| Receipt number | R000059893 |
| Scientific Title | The combined effect of medium-chain fatty acids (octanoic acid and decanoic acid) and exercise on the maintenance of muscle strength - A systematic review |
| Date of disclosure of the study information | 2023/10/13 |
| Last modified on | 2025/04/09 09:21:04 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The combined effect of medium-chain fatty acids (octanoic acid and decanoic acid) and exercise on the maintenance of muscle strength - A systematic review
Acronym
The combined effect of medium-chain fatty acids (octanoic acid and decanoic acid) and exercise on the maintenance of muscle strength - A systematic review
Scientific Title
The combined effect of medium-chain fatty acids (octanoic acid and decanoic acid) and exercise on the maintenance of muscle strength - A systematic review
Scientific Title:Acronym
The combined effect of medium-chain fatty acids (octanoic acid and decanoic acid) and exercise on the maintenance of muscle strength - A systematic review
Region
| Japan |
Condition
Condition
people who are not suffering from any illness
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The purpose of this study is to investigate the effect of combined ingestion of medium-chain fatty acids (octanoic acid and decanoic acid) and exercise on the maintenance of muscle strength
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
muscle strength related outcome(lower limb muscle strength, upper limb muscle strength, grip strength)
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 25 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
people who are not suffering from any illness
Key exclusion criteria
people who are suffering from illness and less than 18 years and pregnant
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | Naohisa |
| Middle name | |
| Last name | Nosaka |
Organization
The Nisshin OilliO Group, Ltd.
Division name
Central research laboratory
Zip code
2358558
Address
1 Shinmori-cho, Isogo-ku, Yokohama, Kanagawa, Japan
TEL
045-757-5461
n-nosaka@nisshin-oillio.com
Public contact
Name of contact person
| 1st name | Naohisa |
| Middle name | |
| Last name | Nosaka |
Organization
The Nisshin OilliO Group, Ltd.
Division name
Central research laboratory
Zip code
2358558
Address
1 Shinmori-cho, Isogo-ku, Yokohama, Kanagawa, Japan
TEL
045-757-5461
Homepage URL
n-nosaka@nisshin-oillio.com
Sponsor or person
Institute
Yakujihou Marketing Jimusho
Institute
Department
Personal name
Funding Source
Organization
The Nisshin OilliO Group, Ltd.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
The Nisshin OilliO Group, Ltd.
Address
1 Shinmori-cho, Isogo-ku, Yokohama, Kanagawa, Japan
Tel
045-757-5461
n-nosaka@nisshin-oillio.com
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2023 | Year | 10 | Month | 13 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2023 | Year | 09 | Month | 04 | Day |
Date of IRB
Anticipated trial start date
| 2023 | Year | 09 | Month | 11 | Day |
Last follow-up date
| 2023 | Year | 10 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
| 2023 | Year | 11 | Month | 21 | Day |
Date analysis concluded
| 2024 | Year | 11 | Month | 24 | Day |
Other
Other related information
This research review will be conducted in accordance with PRISMA 2020
Management information
Registered date
| 2023 | Year | 10 | Month | 13 | Day |
Last modified on
| 2025 | Year | 04 | Month | 09 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059893
